The substitution of a pyrrolide ring for one (or more) pyridyl rings within the ubiquitous terpyridine (tpy, A) scaffold results in more open geometries of the pyridine-pyrrolide chelate ligands. DFT calculations (B3LYP-GD3BJ/6-31G**) demonstrate that the more open geometries of the unbound ligands are mismatched with the "pinched in" geometries required to chelate transition metal ions (e.g., Zn). The strain which builds within these ligands (Δ E) as they bind transition metal ions can be related to changes in a single geometric parameter: the separation between the two terminal N atoms (ρ). This relationship applies more generally to other three-ringed tridentate pincer ligands, including those with different donor groups. The approach was applied to homoleptic iron(II) complexes to investigate the contribution of the steric effects operating within the ligands to the different magnetic properties, including spin crossover (SCO) activities, of these systems.
A family
of five easily prepared tridentate monoanionic 2,5-dipyridyl-3-(R1)-4-(R2)-pyrrolide anions (dppR1,R2)−, varying in the nature of the R1 and R2 substituents [R1, R2 = CN, Ph; CO2Et, CO2Et; CO2Me, 4-Py; CO2Me, Me; Me, Me], has been used to generate the analogous family of
neutral [CoII(dppR1,R2)2] complexes,
two of which are structurally characterized at both 100 and 298 K.
Both the oxidation and spin states of these complexes can be switched
in response to appropriate external stimuli. All complexes, except
[CoII(dppMe,Me)2], exhibit gradual
spin crossover (SCO) in the solid state, and SCO activity is observed
for three complexes in CDCl3 solution. The cobalt(II) centers
in the low spin (LS) complexes are Jahn–Teller tetragonally
compressed along the pyrrolide-Co-pyrrolide axis. The complexes in
their high spin (HS) states are more distorted than in the LS states,
as is also usually the case for SCO active iron(II) complexes. The
reversible CoIII/II redox potentials are predictably tuned
by choice of substituents R1 and R2, from −0.95
(Me,Me) to −0.45 (CN,Ph) V vs Fc+/Fc, with a linear
correlation observed between
E
1
/
2(CoIII/II) and the Swain–Lupton
parameters of the pyrrolide substituents.
Tuned by the ligand field, some single metal atoms in coordination complexes can offer two redox processes with a large potential difference, a key characteristic of symmetrical redox flow batteries...
A series of iron(IV) oxo complexes, which differ in the donor (CH 2 py or CH 2 COO − ) cis to the oxo group, three with hemilabile pendant donor/second coordination sphere base/acid arms (pyH/py or ROH), have been prepared in water at pH 2 and 7. The ν FeO values of 832 ± 2 cm −1 indicate similar Fe IV O bond strengths; however, different reactivities toward C−H substrates in water are observed. HAT occurs at rates that differ by 1 order of magnitude with nonclassical KIEs (k H /k D = 30−66) consistent with hydrogen atom tunneling. Higher KIEs correlate with faster reaction rates as well as a greater thermodynamic stability of the iron(III) resting states. A doubling in rate from pH 7 to pH 2 for substrate C−H oxidation by the most potent complex, that with a cis-carboxylate donor, [Fe IV O(Htpena)] 2+ , is observed. Supramolecular assistance by the first and second coordination spheres in activating the substrate is proposed. The lifetime of this complex in the absence of a C−H substrate is the shortest (at pH 2, 3 h vs up to 1.3 days for the most stable complex), implying that slow water oxidation is a competing background reaction. The iron(IV)O complex bearing an alcohol moiety in the second coordination sphere displays significantly shorter lifetimes due to a competing selective intramolecular oxidation of the ligand.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.